Avience Biomedicals Ltd IPO

The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose its to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.

The company is dependent on certain customers for a portion of its revenues. The loss of any of its major customers dues to any adverse development or significant reduction in business from its major customers may adversely affect the company business, financial condition, results of operations and future prospects.

The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also faces risks in sourcing raw materials and components from third parties for the manufacturing and assembly of its medical equipment. Any disruption in the supply of these goods or materials could adversely impact the company business, operations, and financial condition.

The company Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors of its Company as required under the provisions of ICDR.

The company business derives a significant portion of its revenue from the trading sector, and any potential instability in this area could pose a risk to the company overall performance.

The purchase and sale of medical devices and equipment for the company trading activities is significantly dependent on related parties.

Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negatively impact the company business, financial condition, and operational results.

The company requires sizeable amounts of working capital for its continued operation and growth. The company inability to meet its working capital requirements could has a material adverse effect on the company business, results of operations and financial condition.

The company business depends on the efficient functioning of its manufacturing facilities and assembly units. Although the company has not received any product-related complaints, occasional machinery breakdowns in the past highlight the importance of regular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair could has an adverse impact on the company operations, cash flows, financial condition, and results.

The company import a portion of its raw material supply from China. Restrictions on or import duties relating to materials and equipment imported for the company manufacturing operations as well as restrictions on or import duties levied on its products in the company export markets may adversely affect its business prospects, financial performance and cash flows.